Thought Leadership
Explore Sciensus' Thought Leadership hub, featuring expert insights, innovative ideas, and deep dives into key topics shaping the industry. Stay informed with articles, whitepapers, and perspectives from our thought leaders.
Thought Leadership
Rare diseases
Most Favoured Nation (MFN) & International Reference Pricing (IRP) for Orphan Medicines
Thought Leadership
Long-term conditions
Clinical homecare and coopetition: strengthening safety, innovation and patient experience
Thought Leadership
Long-term conditions
Why clinical homecare should sit at the centre of UK pharma launch strategy
Thought Leadership
Rare diseases
Improving treatment access for rare disease patients and caregivers in Europe
Thought Leadership
Rare diseases
Why do rare disease patients still face barriers to accessing medicines across Europe?
Thought Leadership
Rare diseases
From innovation to access: securing the last mile in rare disease
Thought Leadership
Rare diseases
Rare disease launch insights report
Thought Leadership
Why out-licensing your drug is not always the best option: a smarter route to Europe
Thought Leadership
Rare diseases
Empowering the patient voice